Fig. 3From: Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched studyPropensity score (PS)-matched survival curves of patients by treatment with triweekly XELOX vs. capecitabine. a PS-matched analysis of distant metastasis-free survival; b PS-matched analysis of overall survival; c PS-matched analysis of disease-free survivalBack to article page